title: Mineral Trioxide Aggregate with or without Calcium Chloride in Pulpotomy.
abstract: The aim of this study was to evaluate the reaction of the pulp tissue against mineral trioxide aggregate (MTA) with or without 10% calcium chloride (CaCl(2)). Pulpotomies were performed in 4 canines and 8 premolars of two 8-month-old dogs. MTA with or without CaCl(2) was applied on the pulp tissue. The animals were killed after 90 days, and the specimens were processed for the microscopic analysis. Pulp tissue response was similar for MTA with and without CaCl(2). Pulp vitality was present in all specimens, along with pulp repair with formation of mineralized tissue bridging. The addition of CaCl(2) to MTA did not change its biologic properties in formation of mineralized barrier after pulpotomy.
authors.affiliation: Department of Endodontics, School of Dentistry, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil. edubortoluzzi@hotmail.com
authors.forename: Eduardo Antunes
authors.initials: EA
authors.lastname: Bortoluzzi
authors.forename: Norberto Juárez
authors.initials: NJ
authors.lastname: Broon
authors.forename: Clovis Monteiro
authors.initials: CM
authors.lastname: Bramante
authors.forename: Alberto
authors.initials: A
authors.lastname: Consolaro
authors.forename: Roberto Brandão
authors.initials: RB
authors.lastname: Garcia
authors.forename: Ivaldo Gomes
authors.initials: IG
authors.lastname: de Moraes
authors.forename: Norberti
authors.initials: N
authors.lastname: Bernadineli
mesh_terms: D017607:Aluminum Compounds / Q000627:therapeutic use*; D000818:Animals; D001641:Bicuspid / Q000187:drug effects; D002122:Calcium Chloride / Q000627:therapeutic use*; D017610:Calcium Compounds / Q000627:therapeutic use*; D003481:Cuspid / Q000187:drug effects; D003723:Dental Amalgam; D003782:Dental Pulp / Q000187:drug effects / Q000473:pathology; D003786:Dental Pulp Cavity / Q000187:drug effects / Q000473:pathology; D003793:Dental Restoration, Permanent; D003809:Dentin, Secondary / Q000187:drug effects / Q000473:pathology; D004285:Dogs; D004338:Drug Combinations; D008768:Methylmethacrylates / Q000627:therapeutic use; D009804:Odontoblasts / Q000187:drug effects / Q000473:pathology; D010087:Oxides / Q000627:therapeutic use*; D011672:Pulpotomy; D011897:Random Allocation; D012387:Root Canal Filling Materials / Q000627:therapeutic use*; D017640:Silicates / Q000627:therapeutic use*; D013997:Time Factors; D015035:Zinc Oxide-Eugenol Cement / Q000627:therapeutic use
chemical_list: D017607:Aluminum Compounds; D017610:Calcium Compounds; D004338:Drug Combinations; D008768:Methylmethacrylates; D010087:Oxides; D012387:Root Canal Filling Materials; D017640:Silicates; D015035:Zinc Oxide-Eugenol Cement; C086631:mineral trioxide aggregate; C031667:IRM cement; D003723:Dental Amalgam; D002122:Calcium Chloride